U.S. Markets open in 3 hrs 2 mins
  • S&P Futures

    4,561.75
    -14.00 (-0.31%)
     
  • Dow Futures

    34,526.00
    -96.00 (-0.28%)
     
  • Nasdaq Futures

    15,940.00
    -48.50 (-0.30%)
     
  • Russell 2000 Futures

    2,196.00
    -9.20 (-0.42%)
     
  • Crude Oil

    68.06
    +1.56 (+2.35%)
     
  • Gold

    1,773.20
    +10.50 (+0.60%)
     
  • Silver

    22.35
    +0.04 (+0.17%)
     
  • EUR/USD

    1.1319
    +0.0013 (+0.1132%)
     
  • 10-Yr Bond

    1.4480
    0.0000 (0.00%)
     
  • Vix

    28.15
    -2.97 (-9.54%)
     
  • GBP/USD

    1.3270
    -0.0032 (-0.2415%)
     
  • USD/JPY

    113.2700
    +0.0610 (+0.0539%)
     
  • BTC-USD

    57,005.48
    +721.54 (+1.28%)
     
  • CMC Crypto 200

    1,454.05
    +15.17 (+1.05%)
     
  • FTSE 100

    7,137.99
    +8.78 (+0.12%)
     
  • Nikkei 225

    28,029.57
    +276.20 (+1.00%)
     

Is It Too Late to Buy Novavax Stock?

·5 min read
Is It Too Late to Buy Novavax Stock?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Investors looking for exposure to the coronavirus vaccine market may naturally gravitate toward the two leaders in this segment, Moderna and Pfizer. One of those is biotech Novavax (NASDAQ: NVAX), a company whose shares are up by an impressive 5,630% since January 2020. Despite this amazing performance, Novavax has yet to market its potential COVID-19 vaccine, NVX-CoV2373.